Nektar Therapeutics NKTR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.74M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 45.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 18.07% to 19.82% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +862,623 | 5.2% |
| Two Seas Capital LP | Hedge Fund | 2026/Q3 | +253,744 | 9.8% |
| Citigroup Inc. | Public Company | 2026/Q3 | +178,065 | 0.8% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +96,720 | 0.3% |
| ACT Capital Management | Hedge Fund | 2026/Q3 | +90,400 | 0.5% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +83,927 | 0.3% |
| Two Seas Capital LP | Hedge Fund | 2026/Q3 | +253,744 | 9.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,249,201 | 8.6% |
| FMR | Mutual Fund | 2026/Q3 | +764,713 | 14.8% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +715,000 | 2.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +664,952 | 2.7% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +534,511 | 2.6% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +370,061 | 5.1% |
| Gilder Gagnon Howe & Co. LLC | Mutual Fund | 2026/Q3 | +329,115 | 1.8% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +300,000 | 0.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 22 Sep 2026 | Robert Chess | Independent Chairperson | Other Acquisition | +2,000 | – | 2,000 |
| 22 Sep 2026 | Robert Chess | Independent Chairperson | Other Derivative Acquisition | +4,000 | $57.66 | 4,000 |
| 22 Sep 2026 | R. Greer | Independent Director | Other Acquisition | +2,000 | – | 2,000 |
| 22 Sep 2026 | R. Greer | Independent Director | Other Derivative Acquisition | +4,000 | $57.66 | 4,000 |
| 22 Sep 2026 | Roy Whitfield | Lead Independent Director | Other Acquisition | +2,000 | – | 2,000 |
| 22 Sep 2026 | Roy Whitfield | Lead Independent Director | Other Derivative Acquisition | +4,000 | $57.66 | 4,000 |
| 22 Sep 2026 | Jeffrey Ajer | Independent Director | Other Acquisition | +2,000 | – | 2,000 |
| 22 Sep 2026 | Jeffrey Ajer | Independent Director | Other Derivative Acquisition | +4,000 | $57.66 | 4,000 |
| 22 Sep 2026 | Diana Brainard | Independent Director | Other Acquisition | +2,000 | – | 2,000 |
| 22 Sep 2026 | Diana Brainard | Independent Director | Other Derivative Acquisition | +4,000 | $57.66 | 4,000 |
| 17 Aug 2026 | Howard Robin | Chief Executive Officer | Open Market Disposition | -418 | $71.98 | 54,655 |
| 17 Aug 2026 | Jonathan Zalevsky | Senior VP and Chief Research & Development Officer | Open Market Disposition | -186 | $71.98 | 9,570 |
| 23 Jul 2026 | Howard Robin | Chief Executive Officer | Other Derivative Acquisition | +57,200 | $15.15 | 57,200 |
| 23 Jul 2026 | Jonathan Zalevsky | Senior VP and Chief Research & Development Officer | Other Derivative Acquisition | +16,500 | $15.15 | 16,500 |
| 29 Jun 2026 | Jonathan Zalevsky | Senior VP and Chief Research & Development Officer | Automatic Disposition | -5,681 | $70.00 | 9,756 |
| 16 Jun 2026 | Howard Robin | Chief Executive Officer | Intent to Sell (Form 144) | -10,000 | $60.27 | – |
| 16 Jun 2026 | Howard Robin | Chief Executive Officer | Automatic Disposition | -20,000 | $61.65 | 55,073 |
| 15 Jun 2026 | Howard Robin | Chief Executive Officer | Intent to Sell (Form 144) | -10,000 | $60.96 | – |
| 14 Jun 2026 | Jonathan Zalevsky | Senior VP and Chief Research & Development Officer | Automatic Disposition | -5,538 | $60.71 | 15,437 |
| 18 May 2026 | Howard Robin | Chief Executive Officer | Open Market Disposition | -444 | $65.51 | 75,073 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,766,027 | 19.8% | 10.3 |
| 15 Oct 2026 | 6,997,725 | 20.5% | 3.5 |
| 30 Sep 2026 | 6,968,325 | 20.4% | 3.8 |
| 15 Sep 2026 | 5,735,633 | 16.8% | 7.6 |
| 31 Aug 2026 | 6,068,214 | 17.8% | 11.5 |
| 14 Aug 2026 | 6,168,872 | 18.1% | 10.4 |
No comments yet — be the first to weigh in on NKTR.
Sign in to join the discussion.